US 11,732,302 B2
Methods and systems for processing polynucleotides
Phillip Belgrader, Livermore, CA (US); Josephine Harada, San Francisco, CA (US); Tarjei Sigurd Mikkelsen, Dublin, CA (US); Katherine Pfeiffer, Berkeley, CA (US); Serge Saxonov, Oakland, CA (US); and John R. Stuelpnagel, Santa Barbara, CA (US)
Assigned to 10X Genomics, Inc., Pleasanton, CA (US)
Filed by 10X GENOMICS, INC., Pleasanton, CA (US)
Filed on Jun. 2, 2022, as Appl. No. 17/831,356.
Application 17/831,356 is a continuation of application No. 17/529,229, filed on Nov. 17, 2021.
Application 17/529,229 is a continuation of application No. 17/175,465, filed on Feb. 12, 2021, granted, now 11,248,267, issued on Feb. 15, 2022.
Application 17/175,465 is a continuation of application No. 16/773,750, filed on Jan. 27, 2020, granted, now 10,954,562, issued on Mar. 23, 2021.
Application 16/773,750 is a continuation of application No. 16/692,631, filed on Nov. 22, 2019, granted, now 10,793,905, issued on Oct. 6, 2020.
Application 16/692,631 is a continuation of application No. 16/426,762, filed on May 30, 2019, granted, now 10,550,429, issued on Feb. 4, 2020.
Application 16/426,762 is a continuation in part of application No. 15/933,299, filed on Mar. 22, 2018, granted, now 10,480,029, issued on Nov. 19, 2019.
Application 15/933,299 is a continuation of application No. 15/720,085, filed on Sep. 29, 2017, granted, now 10,011,872, issued on Jul. 3, 2018.
Application 16/426,762 is a continuation of application No. PCT/US2017/068320, filed on Dec. 22, 2017.
Application PCT/US2017/068320 is a continuation in part of application No. 15/720,085, filed on Sep. 29, 2017, granted, now 10,011,872, issued on Jul. 3, 2018.
Claims priority of provisional application 62/438,341, filed on Dec. 22, 2016.
Prior Publication US 2022/0307082 A1, Sep. 29, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. C12Q 1/6874 (2018.01); C12N 15/10 (2006.01); C12Q 1/683 (2018.01); C12Q 1/6804 (2018.01); C12Q 1/6806 (2018.01)
CPC C12Q 1/6874 (2013.01) [C12N 15/1075 (2013.01); C12Q 1/683 (2013.01); C12Q 1/6804 (2013.01); C12Q 1/6806 (2013.01); C12Q 2525/191 (2013.01); C12Q 2537/143 (2013.01); C12Q 2563/179 (2013.01)] 48 Claims
 
1. A composition comprising a support comprising
(i) a first nucleic acid barcode molecule comprising a barcode sequence and an immune receptor-specific primer sequence; and
(ii) a second nucleic acid barcode molecule comprising the barcode sequence and a poly-T primer sequence.